These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24632958)

  • 1. Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein.
    Yasunaga T; Ikeda S; Koga S; Nakata T; Yoshida T; Masuda N; Kohno S; Maemura K
    Int Heart J; 2014; 55(2):160-4. PubMed ID: 24632958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.
    Yilmaz MI; Axelsson J; Sonmez A; Carrero JJ; Saglam M; Eyileten T; Caglar K; Kirkpantur A; Celik T; Oguz Y; Vural A; Yenicesu M; Lindholm B; Stenvinkel P
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):535-41. PubMed ID: 19211665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events.
    Huang PH; Chen JW; Lu TM; Yu-An Ding P; Lin SJ
    Clin Cardiol; 2007 Mar; 30(3):135-40. PubMed ID: 17385705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases: A Quasi-Experimental Study.
    Yilmaz MI; Romano M; Basarali MK; Elzagallaai A; Karaman M; Demir Z; Demir MF; Akcay F; Seyrek M; Haksever N; Piskin D; Cimaz R; Rieder MJ; Demirkaya E
    Sci Rep; 2020 Jun; 10(1):9018. PubMed ID: 32488098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-dependent pentraxin-3 and reactive oxygen species production modulate endothelial dysfunction in haemodialysis patients.
    dell'Oglio MP; Simone S; Ciccone M; Corciulo R; Gesualdo M; Zito A; Cortese F; Castellano G; Gigante M; Gesualdo L; Grandaliano G; Pertosa GB
    Nephrol Dial Transplant; 2017 Sep; 32(9):1540-1549. PubMed ID: 27915246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Weiner SD; Ahmed HN; Jin Z; Cushman M; Herrington DM; Nelson JC; Di Tullio MR; Homma S
    Heart; 2014 Jun; 100(11):862-6. PubMed ID: 24714919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.
    Hudzik B; Danikiewicz A; Szkodzinski J; Polonski L; Zubelewicz-Szkodzinska B
    Eur Cytokine Netw; 2014; 25(3):41-5. PubMed ID: 25373851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
    Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
    J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of endothelial dysfunction measured by flow-mediated vasodilatation to severity of coronary artery disease.
    Sancheti S; Shah P; Phalgune DS
    Indian Heart J; 2018; 70(5):622-626. PubMed ID: 30392498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation.
    Hudzik B; Szkodzinski J; Pietka-Rzycka A; Danikiewicz A; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
    J Interferon Cytokine Res; 2013 May; 33(5):280-4. PubMed ID: 23414296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus.
    Yang HS; Woo JE; Lee SJ; Park SH; Woo JM
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5989-97. PubMed ID: 25159210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction.
    Sakr SA; Abbas TM; Amer MZ; Dawood EM; El-Shahat N; Abdel Aal IA; Ramadan MM
    Int Heart J; 2009 Jul; 50(4):407-19. PubMed ID: 19609046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation.
    Haibo L; Xiaofang G; Chunming W; Jie Y; Guozhong C; Limei Z; Yong C; Yu F; Yingchun B; Wangjun Y; Junbo G
    Mediators Inflamm; 2014; 2014():963096. PubMed ID: 25538378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired blood rheology is associated with endothelial dysfunction in patients with coronary risk factors.
    Yagi H; Sumino H; Aoki T; Tsunekawa K; Araki O; Kimura T; Nara M; Ogiwara T; Murakami M
    Clin Hemorheol Microcirc; 2016; 62(2):139-50. PubMed ID: 26444592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
    Lee SJ; Lee DW; Kim KS; Lee IK
    Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.
    Yilmaz MI; Sonmez A; Ortiz A; Saglam M; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Çakar M; Egido J; Altun B; Yenicesu M; Blanco-Colio LM; Carrero JJ
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):785-92. PubMed ID: 21330486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of acute infection-induced endothelial dysfunction and its potential mediators.
    Kilickap M; Goksuluk H; Candemir B; Kaya CT; Ozcan OU; Turhan S; Vurgun K; Ozdemir AO; Erol C
    Acta Cardiol; 2011 Oct; 66(5):581-7. PubMed ID: 22032051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lower extremity revascularization on the endothelial functions measured with noninvasive brachial artery flow-mediated dilatation.
    Unal O; Karatepe O; Ugurlucan M; Koc B; Filizcan U; Aksoy M
    Ann Vasc Surg; 2011 Oct; 25(7):969-74. PubMed ID: 21530156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influencing factors of vascular endothelial function in patients with non-obstructive coronary atherosclerosis: a 1-year observational study.
    Li YP; Fan ZX; Gao J; Sun XP; Zhu GH; Zhang YH; Si J; Zuo XB; Liu Z; Hua Q; Li J
    BMC Cardiovasc Disord; 2020 Jan; 20(1):40. PubMed ID: 32000667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.